Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

Schoonenboom NS, van der Flier WM, Blankenstein MA, Bouwman FH, Van Kamp GJ, Barkhof F, Scheltens P.

Neurobiol Aging. 2008 May;29(5):669-75. Epub 2007 Jan 17.

PMID:
17208336
2.

CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging.

Pijnenburg YA, Schoonenboom SN, Barkhof F, Knol DL, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P.

J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):246-8.

3.
4.

The transmethylation cycle in the brain of Alzheimer patients.

Mulder C, Schoonenboom NS, Jansen EE, Verhoeven NM, van Kamp GJ, Jakobs C, Scheltens P.

Neurosci Lett. 2005 Sep 30;386(2):69-71.

PMID:
16040194
5.

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA, Mehta PD.

Ann Neurol. 2005 Jul;58(1):139-42.

PMID:
15984010
6.

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.

Schoonenboom NS, Mulder C, Vanderstichele H, Pijnenburg YA, Van Kamp GJ, Scheltens P, Mehta PD, Blankenstein MA.

Clin Chem. 2005 Jun;51(6):1057-60. Epub 2005 Apr 21. No abstract available.

7.

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.

Schoonenboom SN, Visser PJ, Mulder C, Lindeboom J, Van Elk EJ, Van Kamp GJ, Scheltens PH.

Neurocase. 2005 Feb;11(1):8-13.

PMID:
15804919
8.

The impact of heparin coated circuits upon metabolism in vital organs: effect upon cerebral and renal function during and after cardiopulmonary bypass.

de Vroege R, Stooker W, van Oeveren W, Bakker EW, Huybregts RA, van Klarenbosch J, van Kamp GJ, Hack CE, Eijsman L, Wildevuur CR.

ASAIO J. 2005 Jan-Feb;51(1):103-9.

PMID:
15745143
9.

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA.

Clin Chem. 2005 Jan;51(1):189-95. Epub 2004 Nov 11.

10.

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.

Zwemmer JN, van Veen T, van Winsen L, van Kamp GJ, Barkhof F, Polman CH, Uitdehaag BM.

Mult Scler. 2004 Jun;10(3):272-7.

PMID:
15222690
11.

CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration.

Pijnenburg YA, Schoonenboom NS, Rosso SM, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P.

Neurology. 2004 May 11;62(9):1649. No abstract available.

PMID:
15136709
12.

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P.

Neurology. 2004 May 11;62(9):1580-4.

PMID:
15136685
13.

Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.

Davelaar EM, Schutter EM, von Mensdorff-Pouilly S, van Kamp GJ, Verstraeten RA, Kenemans P.

Ann Clin Biochem. 2003 Nov;40(Pt 6):663-73.

PMID:
14629806
14.

Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease.

Mulder C, Wahlund LO, Teerlink T, Blomberg M, Veerhuis R, van Kamp GJ, Scheltens P, Scheffer PG.

J Neural Transm (Vienna). 2003 Aug;110(8):949-55.

PMID:
12898349
15.

Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients.

Stieber P, Molina R, Chan DW, Fritsche HA, Beyrau R, Bonfrer JM, Filella X, Gornet TG, Hoff T, Jäger W, van Kamp GJ, Nagel D, Peisker K, Sokoll LJ, Troalen F, Untch M, Domke I.

Clin Lab. 2003;49(1-2):15-24.

PMID:
12593471
16.

CSF markers related to pathogenetic mechanisms in Alzheimer's disease.

Mulder C, Schoonenboom SN, Wahlund LO, Scheltens P, van Kamp GJ, Veerhuis R, Hack CE, Blomberg M, Schutgens RB, Eikelenboom P.

J Neural Transm (Vienna). 2002 Dec;109(12):1491-8.

PMID:
12486489
17.

Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.

Jongsma AP, Piek JM, Zweemer RP, Verheijen RH, Klein Gebbinck JW, van Kamp GJ, Jacobs IJ, Shaw P, van Diest PJ, Kenemans P.

Mol Pathol. 2002 Oct;55(5):305-9.

18.

Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid.

Mulder C, Wahlund LO, Blomberg M, de Jong S, van Kamp GJ, Scheltens P, Teerlink T.

J Neural Transm (Vienna). 2002 Sep;109(9):1203-8.

PMID:
12203047
19.
20.

The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass.

Schutter EM, Davelaar EM, van Kamp GJ, Verstraeten RA, Kenemans P, Verheijen RH.

Am J Obstet Gynecol. 2002 Aug;187(2):385-92.

PMID:
12193930
21.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
22.

Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay.

Stieber P, Molina R, Chan DW, Fritsche HA, Beyrau R, Bonfrer JM, Filella X, Gornet TG, Hoff T, Jäger W, van Kamp GJ, Nagel D, Peisker K, Sokoll LJ, Troalen F, Untch M, Domke I.

Clin Chem. 2001 Dec;47(12):2162-4. No abstract available.

23.

Maternal serum Ca125 and Ca15-3 antigen levels in normal and pathological pregnancy.

Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ, van Geijn HP, van Vugt JM.

Fetal Diagn Ther. 2001 May-Jun;16(3):166-72.

PMID:
11316933
24.

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

Colnot DR, Quak JJ, Roos JC, van Lingen A, Wilhelm AJ, van Kamp GJ, Huijgens PC, Snow GB, van Dongen GA.

J Nucl Med. 2000 Dec;41(12):1999-2010.

25.

[Apolipoprotein E4 and memory decline in the elderly].

Jonker C, Dik MG, van Kamp GJ, Deeg DJ.

Tijdschr Gerontol Geriatr. 2000 Oct;31(5):198-202. Dutch.

PMID:
11064931
26.

Genetic and biochemical markers for Alzheimer's disease: recent developments.

Mulder C, Scheltens P, Visser JJ, van Kamp GJ, Schutgens RB.

Ann Clin Biochem. 2000 Sep;37 ( Pt 5):593-607. Review. No abstract available.

PMID:
11026514
27.

Maternal thromboxane and prostacyclin levels in relation to fetal birth weight.

de Jong CL, Paarlberg KM, van Geijn HP, van Kamp GJ, van Dis H, Dekker GA.

Eur J Obstet Gynecol Reprod Biol. 2000 Nov;93(1):65-9.

PMID:
11000507
28.

Modulation of plasma endothelin levels by the menstrual cycle.

Polderman KH, Stehouwer CD, van Kamp GJ, Schalkwijk CG, Gooren LJ.

Metabolism. 2000 May;49(5):648-50.

PMID:
10831177
29.

Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.

von Mensdorff-Pouilly S, Petrakou E, Kenemans P, van Uffelen K, Verstraeten AA, Snijdewint FG, van Kamp GJ, Schol DJ, Reis CA, Price MR, Livingston PO, Hilgers J.

Int J Cancer. 2000 Jun 1;86(5):702-12.

30.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
31.

Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.

Schutter EM, Mijatovic V, Kok A, Van Kamp GJ, Verstraeten R, Verheijen RH.

Anticancer Res. 1999 Nov-Dec;19(6C):5551-7.

PMID:
10697615
32.

Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, Snijdewint FG, Kok A, Van Kamp GJ, Paul MA, Van Diest PJ, Meijer S, Hilgers J.

J Clin Oncol. 2000 Feb;18(3):574-83.

PMID:
10653872
33.

Quantification of MUC1 in breast cancer patients. A method comparison study.

Bon GG, van Kamp GJ, Verstraeten RA, von Mensdorff-Pouilly S, Hilgers J, Kenemans P.

Eur J Obstet Gynecol Reprod Biol. 1999 Mar;83(1):67-75.

PMID:
10221613
34.

CA 125: fundamental and clinical aspects.

Verheijen RH, von Mensdorff-Pouilly S, van Kamp GJ, Kenemans P.

Semin Cancer Biol. 1999 Apr;9(2):117-24. Review.

PMID:
10202133
35.

Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles.

Bon GG, Kenemans P, Dekker JJ, Hompes PG, Verstraeten RA, van Kamp GJ, Schoemaker J.

Hum Reprod. 1999 Feb;14(2):566-70.

PMID:
10100011
36.

Changes in lipid, lipoprotein and apolipoprotein profiles in persons with spinal cord injuries during the first 2 years post-injury.

Dallmeijer AJ, van der Woude LH, van Kamp GJ, Hollander AP.

Spinal Cord. 1999 Feb;37(2):96-102.

PMID:
10065747
37.

Tumor markers in retinoblastoma.

Mul D, Schouten-van Meeteren AY, van Kamp GJ, Tan KE.

Med Pediatr Oncol. 1999 Feb;32(2):146-7. Review. No abstract available.

PMID:
9950205
38.

Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study.

Paarlberg KM, de Jong CL, van Geijn HP, van Kamp GJ, Heinen AG, Dekker GA.

Am J Obstet Gynecol. 1998 Dec;179(6 Pt 1):1559-64.

PMID:
9855596
39.

Maternal and fetal plasma concentrations of endothelin, lipidhydroperoxides, glutathione peroxidase and fibronectin in relation to abnormal umbilical artery velocimetry.

Karsdorp VH, Dekker GA, Bast A, van Kamp GJ, Bouman AA, van Vugt JM, van Geijn HP.

Eur J Obstet Gynecol Reprod Biol. 1998 Sep;80(1):39-44.

PMID:
9758257
40.

Comparison of seven immunoassays for the quantification of CA 125 antigen in serum.

Davelaar EM, van Kamp GJ, Verstraeten RA, Kenemans P.

Clin Chem. 1998 Jul;44(7):1417-22.

41.

The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.

van Kesteren PJ, Kooistra T, Lansink M, van Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, Stehouwer CD.

Thromb Haemost. 1998 May;79(5):1029-33.

PMID:
9609242
42.

An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).

von Mensdorff-Pouilly S, Gourevitch MM, Kenemans P, Verstraeten AA, van Kamp GJ, Kok A, van Uffelen K, Snijdewint FG, Paul MA, Meijer S, Hilgers J.

Tumour Biol. 1998;19(3):186-95.

PMID:
9591045
43.

Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study.

Paarlberg KM, de Jong CL, van Geijn HP, van Kamp GJ, Heinen AG, Dekker GA.

Obstet Gynecol. 1998 Mar;91(3):383-8.

PMID:
9491865
44.

The use of biliary CEA measurements in the diagnosis of recurrent colorectal cancer.

Paul MA, Visser JJ, Mulder C, van Kamp GJ, Cuesta MA, Meijer S.

Eur J Surg Oncol. 1997 Oct;23(5):419-23.

PMID:
9393570
45.

Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.

Mijatovic V, Kenemans P, Netelenbos JC, Peters-Muller ER, van Kamp GJ, Voetberg GA, van de Weijer PH, van der Mooren MJ.

J Clin Endocrinol Metab. 1997 Nov;82(11):3543-7.

PMID:
9360504
46.

Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood.

Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM.

Am J Gastroenterol. 1997 Sep;92(9):1480-2.

PMID:
9317067
47.

Coronary heart disease risk indicators, aerobic power, and physical activity in men with spinal cord injuries.

Janssen TW, van Oers CA, van Kamp GJ, TenVoorde BJ, van der Woude LH, Hollander AP.

Arch Phys Med Rehabil. 1997 Jul;78(7):697-705.

PMID:
9228871
48.
49.

Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.

Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, Hilgers J, Meijer S, Vermorken JB.

Clin Chem. 1997 Apr;43(4):585-93.

50.

The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.

Schutter EM, Mulder C, van Kamp GJ, Kenemans P.

Anticancer Res. 1997 Mar-Apr;17(2B):1255-72. Review.

PMID:
9137483

Supplemental Content

Loading ...
Support Center